FindTrial
Sign In

The patient-reported outcome of postoperative Prostaglandin E1 derivative in Lumbar spine surgery: a randomized, double-blinded, controlled trial

The patient-reported outcome of postoperative Prostaglandin E1 derivative in Lumbar spine surgery: a randomized, double-blinded, controlled trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20201010003
Enrollment
60
Registered
2020-10-10
Start date
2021-07-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative leg numbness Prostaglandin E1 derivative Lumbar spine surgery Postoperative outcome Patient reported outcome

Interventions

Prostaglandin E1 derivative,Placebo
Experimental Drug,Placebo Comparator Drug
Limaprost,Placebo

Sponsors

None listed

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.Degenerative lumbar spine disease patients 2.patients who have to undergo lumbar spine surgery (1-2 levels) 3.leg numbness confirmed by Semmes-Weinstein monofilament test 4.age 18-70 years

Exclusion criteria

Exclusion criteria: 1.patients with Lumbar spine disease not caused by denerative disease 2.patients with history of previous Lumbar spine surgery 3.Patients with peripheral vascular disease 4.Pregnancy or Breastfeeding patients 5.Patients who cannot be regular followed up

Design outcomes

Primary

MeasureTime frame
Leg numbness 12 week Visual analog scale—

Secondary

MeasureTime frame
Back pain, leg pain 12 week Visual analog scale—

Countries

Thailand

Contacts

Public ContactKritsada Puttasean

Orthopedics department

pedek-d_k@hotmail.com0852244299

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026